In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Knoll completes purchase of Hokuriku Seiyaku for $255.5mm

Executive Summary

BASF's Knoll Pharmaceutical has completed the purchase of 51% of Hokuriku Seiyaku (Japanese pharma) for $255.5mm, buying 18,980,000 shares of Hokuriku stock at $13.46 per share.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Partial Acquisition
    • Payment Includes Cash

Related Companies